Karnataka

Active

Goods

Re-Tender for the supply of Insulin Injection for various Health Institutions across Karnataka under Annual Indent 2025-26

Karnataka State Medical Supplies Corporation Limited

KSMSCL Managing Director office Bengaluru | Bengaluru, Karnataka

Amount: Refer DocsCloses: 17 Aug 2026

Timeline

Published15 Jul 2026
Pre-Bid Meeting23 Jul 2026
Closes17 Aug 2026
Bid Opening19 Aug 2026

Tender Value

Refer Docs

EMD Value

₹22.2 L

Closing Date

17 Aug 2026, 11:00 pm

Tender Inviting Authority

Office Inviting Bids

Karnataka State Medical Supplies Corporation Limited

Contact Person

RAMESH MANAGER DRUGS

Office Number

08029619801

Mobile Number

8951033347

Work Description

Re-Tender for the supply of Insulin Injection for various Health Institutions across Karnataka under Annual Indent 2025-26

Tender Information

Tender ID

KSMSCL/2026-27/IND0410

Reference Number

KSMSCL/2026-27/IND0410

Tender Type

Open

Form of Contract

Two Tender Document System(Two Cover)

Location

KSMSCL Managing Director office Bengaluru

Source Website

Subscribe to view

Documents Required

35 documents required · 35 mandatory

Technical Bid

RequiredAnnual Turnover, Non-MSE-3 years and MSE-2 years.

RequiredAny other relevant document required as per the tender terms and conditions.

RequiredAppendix 2 & Appendix-2A DESIGNS FOR LOGOGRAMS

RequiredAppendix 3 SCHEDULES FOR PACKAGING OF DRUGS AND MEDICINES.

RequiredAppendix 4 BARCODE REQUIREMENTS AT SHIPPER/CARTON/TERTAIRY LEVEL PACKAGING.

RequiredAppendix 7 Checklist of Documents uploaded Mark the Attached Documents

RequiredAttested copy of Specimen Label Annexure-VIII.

RequiredAudited Statement of Accounts viz. Balance Sheet, Trading/Profit and Loss Account, Non-MSE-3 years and MSE-2 years.

RequiredCapacity Installation Certificate Annexure-IV.

RequiredCertificate issued by the Chartered Accountant as per Annexure II with UDIN Number.

RequiredCertificates issued by Drug Control Department/FDA towards in-house lab approval/details of NABL lab where the quality testing for the quoted drug will be done is to be furnished at the time of submission of Technical Bid/before issuing NOA as per Annexure XIV.

RequiredDeclaration Annexure XII.

RequiredDetails of Bidder Annexure I.

RequiredF.F.S Technology Certificate, Annexure-XI.

RequiredGeneral Power of Attorney Annexure XIII

RequiredGST Registration certificate.

RequiredGST remittance for a period of 3 months up to 31st March 2026.

RequiredIT Returns, Non-MSE-3 years and MSE-2 years.

RequiredManufacturing License

RequiredManufacturing Unit Annexure-III.

RequiredMarket Standing Certificate Annexure-VI.

RequiredNon Conviction Certificate NOC Annexure-IX.

RequiredNSIC registration certificate

RequiredOffered Supply Capacity and Lead Time Required Annexure VII.

RequiredOriginal valid SSI, MSME, UDYAM MSME certificates.

RequiredPerformance Certificate Annexure-XA/B.

RequiredProduct Certification.

RequiredProduct Permission for the drug in IP/BP/USP in addition to previous Product Permission for that drug official in IP/BP/USP. Supporting documents if any to be uploaded.

RequiredProduct Permission/Approval

RequiredProduct Quoted under this Tender Annexure V.

RequiredRegistration certificate such as Incorporation Certificate, Registration of Firms, Partnership deed, Establishment registration Certificate etc.

RequiredScanned copy of the DD Drawn/NEFT/RTGS copy with UTR No/Transaction ID towards tender processing fee Rs. 5900/-.

RequiredSECTION IX Earnest Money Deposit Form.

RequiredSECTION IXB Earnest Money Deposit Bank Guarantee.

RequiredSECTION VIII Tender Form.

Eligibility Criteria

Tenderers should not be associated, or have been associated in the past, directly or indirectly, with a firm or any of its affiliates which have been engaged by the Purchaser to provide consulting services for the preparation of the design, specifications, and other documents to be used for the procurement of the goods to be purchased under this Invitation of Tenders.

Bidders shall not be under a declaration of ineligibility for corrupt and fraudulent practices issued by Government of Karnataka

It shall be the responsibility of the Bidder to ensure credit of Tender Processing Fee and EMD into the respective receiving bank accounts of e-Procurement on or before the last date and time of bid submission.

EMD Payments through e-Payment mode shall be made as one single transaction and payments made in part are liable for rejection.

Technical Criteria

Others

As per tender document

Others -- As per tender document

Fee & Financial Details

Tender Fee Amount

₹500

EMD Fee Amount

₹22.2 L

Important Dates

Last Activity

15 Jul 2026

Published

15 Jul 2026

Bid Opening

19 Aug 2026

Download Ends

24 Jul 2026

Pre-Bid Meeting

23 Jul 2026

BOQ Preview

•

D00675 Insulin Lispro Injection IP 100 U/ml 1x3ml disposable prefilled pens

•

D00674 Degludec insulin Injection 100 U/ml 1x3ml disposable prefilled pens

•

D00679 Biphasic Isophane Insulin Injection IP 100 units/ml COMPOSITION Insulin Isophane (70%) + Human insulin (30%) 1x10ml vial

•

D00676 Biphasic Isophane Insulin Injection IP 40 units/ml COMPOSITION Insulin Isophane (50%) + Human insulin (50%) 1x10ml vial

•

D00677 Insulin Glargine Injection IP100U/ml 1x3ml disposable prefilled pens

•

D00672 Insulin (Soluble) Injection 40 I.U/ml 1x10ml vial

•

D00678 Isophane Insulin Injection IP (NPH) 40 units/ml 1x10ml vial

•

D00673 Insulin Aspart Injection 100U/ml 1x3ml disposable prefilled pens

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

NIT Documents

IND-0410 INSULIN TENDER DOCUMENT 25-26 AI.docx

Tender Document • 1.08 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].